Skip to main content
Caplight Logo









Cascade Bio

Cascade Bio

Private
Denver, ColoradoFrontier & Industrial Techhttps://www.cascadebio.com/

Last Round

Seed

Sep 9, 2025

Total Funding Raised

$8.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cascade Bio is a biotechnology company that develops enzyme immobilization kits to enhance the sustainability and efficiency of chemical manufacturing processes.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Clean Manufacturing, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

enzyme immobilizationbiocatalysisbiomanufacturingindustrial biotechnologybiocatalyst stabilizationsynbioenzyme engineeringbioprocess engineeringgreen chemistrysustainable manufacturingimmobilized enzymepolymer brushessmall business innovation researchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cascade Bio Comparables

Compare Cascade Bio with similar companies based on industry and business-model similarity.

Cascade Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zymtronix
84%
FabricNano
83%
ChiralVision B.V.
83%

Cascade Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 9, 2025
GrantSep 9, 2025
Pre SeedAug 22, 2023

Key People

Founding team and executive leadership

Alex Rosay

CEO And Co-Founder

Founding Team

Cascade Bio Investors

Notable investors and investment history

Cascade Bio investors
InvestorRounds
Cool Climate CollectivePre Seed
Spacecadet VenturesPre Seed
1Flourish CapitalSeed
Amplify.LAPre Seed, Seed
SV Latam CapitalSeed
Boost VCPre Seed
Range VenturesPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 55% MoM.

  • Sep 9, 2025

    Received $3.2M from the National Science Foundation

Cascade Bio Filings

Explore SEC and related filing metadata, where available.

Cascade Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cascade Bio's valuation, stock price, and market status.

Is CascadeBio a public or private company?

CascadeBio is a private company.

What is the current stock price of CascadeBio?

CascadeBio is a private company with no public stock price. No recent secondary market data is available.

How much is CascadeBio worth (valuation)?

Valuation information for CascadeBio is not publicly available.

Can I buy CascadeBio stock?

CascadeBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CascadeBio's last funding round?

CascadeBio's most recent funding round was Grant on September 9, 2025.

Who are the main investors in CascadeBio?

Key investors in CascadeBio include SV Latam Capital, Ten VC.

Will CascadeBio IPO soon?

No public IPO plans have been announced for CascadeBio.

How can I track CascadeBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CascadeBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range11
Year Founded2022
Last FundingSep 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?